Approval · Notice of Compliance 21183 · 2018
CHILDREN'S ADVIL: Notice of Compliance 21183
Issued August 7, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21183
- Date
- August 7, 2018
- Company
- Pfizer Consumer Healthcare, a division of Pfizer Canada ULCMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a new line extension (sugar free/dye free berry formulation
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CHILDREN'S ADVIL | 02232297 | Marketed |
Medicinal ingredients
- IBUPROFEN 100 MG per 5ML